Display options
Cite
Tarantino G, Morelli L, Califano C. Contraccettivi orali e danno epatico. [Oral contraceptive and hepatic effects]. Riv Eur Sci Med Farmacol. 1990;12(3):165-8
Tarantino, G., Morelli, L., & Califano, C. (1990). Contraccettivi orali e danno epatico. [Oral contraceptive and hepatic effects]. Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques, 12(3), 165-8.
Tarantino, G, et al. "Contraccettivi orali e danno epatico." [Oral contraceptive and hepatic effects]. Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques vol. 12,3 (1990): 165-8.
Tarantino G, Morelli L, Califano C. Contraccettivi orali e danno epatico. [Oral contraceptive and hepatic effects]. Riv Eur Sci Med Farmacol. 1990 Jun;12(3):165-8. Italian. PMID: 2101166.
Copy Download .nbib Format: NLM
Share it on

Riv Eur Sci Med Farmacol. 1990 Jun;12(3):165-8.

[Oral contraceptive and hepatic effects].

Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques

[Article in Italian]
G Tarantino, L Morelli, C Califano

Affiliations

  1. Istituto di Medicina Interna e Malattie Dismetaboliche, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli.

PMID: 2101166

Abstract

The general use of synthetic estrogens like DC pointed out that near many skilled collateral effects, some others that are showing with a decrease of bile excretion (cholestasis), reversible with their administration interruption; with hepatic cells adenoma that are potentially premalignant and can transform into hepatocellular carcinoma; with vascular complications such as (most frequently in carcinomatousis) "hepatic peliosis" and "thrombosis" of suprahepatic veins (Budd-Chiari's syndrome). There is no overall increase in the incidence of gallbladder disease (cholelithiasis and cholecystitis).

Substances

MeSH terms

Publication Types

LinkOut - more resources